Segui
Alessandro Pratesi
Titolo
Citata da
Citata da
Anno
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study
T Marzo, D Cirri, C Gabbiani, T Gamberi, F Magherini, A Pratesi, A Guerri, ...
ACS medicinal chemistry letters 8 (10), 997-1001, 2017
1022017
Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear selenocysteine containing C-terminal peptide …
A Pratesi, C Gabbiani, E Michelucci, M Ginanneschi, AM Papini, ...
Journal of Inorganic Biochemistry 136, 161-169, 2014
942014
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis
A Pratesi, C Gabbiani, M Ginanneschi, L Messori
Chemical communications 46 (37), 7001-7003, 2010
722010
Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer
T Marzo, L Massai, A Pratesi, M Stefanini, D Cirri, F Magherini, M Becatti, ...
ACS Medicinal Chemistry Letters 10 (4), 656-660, 2019
662019
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs
D Cirri, A Pratesi, T Marzo, L Messori
Expert opinion on drug discovery 16 (1), 39-46, 2021
652021
Antiproliferative effects of two gold (I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study
F Magherini, T Fiaschi, E Valocchia, M Becatti, A Pratesi, T Marzo, ...
Oncotarget 9 (46), 28042, 2018
582018
ESI MS studies highlight the selective interaction of Auranofin with protein free thiols
C Zoppi, L Messori, A Pratesi
Dalton Transactions 49 (18), 5906-5913, 2020
572020
Selection and characterization of a human ovarian cancer cell line resistant to auranofin
I Landini, A Lapucci, A Pratesi, L Massai, C Napoli, G Perrone, P Pinzani, ...
Oncotarget 8 (56), 96062, 2017
502017
Reactions of medicinal gold (III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods
L Massai, C Zoppi, D Cirri, A Pratesi, L Messori
Frontiers in Chemistry 8, 581648, 2020
462020
Reactions of auranofin and its pseudohalide derivatives with serum albumin investigated through ESI-Q-TOF MS
A Pratesi, D Cirri, L Ciofi, L Messori
Inorganic Chemistry 57 (17), 10507-10510, 2018
462018
Strategies for the improvement of metal-based chemotherapeutic treatments
D Cirri, F Bartoli, A Pratesi, E Baglini, E Barresi, T Marzo
Biomedicines 9 (5), 504, 2021
422021
A fluorescent silver (I) carbene complex with anticancer properties: synthesis, characterization, and biological studies
MG Fabbrini, D Cirri, A Pratesi, L Ciofi, T Marzo, A Guerri, S Nistri, ...
ChemMedChem 14 (1), 182-188, 2019
392019
Ruthenium arene complexes with triphenylphosphane ligands: cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution
L Biancalana, A Pratesi, F Chiellini, S Zacchini, T Funaioli, C Gabbiani, ...
New Journal of Chemistry 41 (23), 14574-14588, 2017
392017
Structural characterization of a gold/serum albumin complex
A Pratesi, D Cirri, D Fregona, G Ferraro, A Giorgio, A Merlino, L Messori
Inorganic Chemistry 58 (16), 10616-10619, 2019
382019
A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes
F Guarra, A Pratesi, C Gabbiani, T Biver
Journal of Inorganic Biochemistry 217, 111355, 2021
342021
The cisplatin/serum albumin system: A reappraisal
L Massai, A Pratesi, J Gailer, T Marzo, L Messori
Inorganica Chimica Acta 495, 118983, 2019
342019
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments
E Michelucci, G Pieraccini, G Moneti, C Gabbiani, A Pratesi, L Messori
Talanta 167, 30-38, 2017
342017
Photocytotoxic Pt (iv) complexes as prospective anticancer agents
G Canil, S Braccini, T Marzo, L Marchetti, A Pratesi, T Biver, T Funaioli, ...
Dalton Transactions 48 (29), 10933-10944, 2019
322019
The NAMI A–human ferritin system: a biophysical characterization
S Ciambellotti, A Pratesi, M Severi, G Ferraro, E Alessio, A Merlino, ...
Dalton Transactions 47 (33), 11429-11437, 2018
322018
Doing care, doing citizenship: Towards a micro-situated and emotion-based model of social inclusion
A Pratesi
Springer, 2017
322017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20